Outcomes of Different Guidewire‐Assisted Techniques for Recurrent Malignant Biliary Obstruction After Uncovered Metallic Stent Placement
Journal of Digestive Diseases · 2026
DOI: 10.1111/1751-2980.70065 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Digestive Diseases, 2026. Verfasst von Qiao Feng Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Diges…. Hauptthemen laut MEDLINE: Cholestasis, Stents, Cholangiopancreatography, Endoscopic Retrograde. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Objectives
We aimed to compare the clinical outcomes of the bent guidewire insertion (BGI) technique and the conventional straight guidewire insertion (SGI) technique for managing recurrent malignant biliary obstruction (RMBO) after initial uncovered metallic stent (UMS) placement.
Methods
Ninety patients who underwent endoscopic intervention for RMBO after UMS placement were retrospectively included. Clinical outcomes and endoscopic retrograde cholangiopancreatography (ERCP)‐related factors were compared between the SGI and BGI groups. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors associated with difficult cannulation.
Results
There were 43 and 47 patients who underwent the SGI and BGI techniques, respectively, for intervention of RMBO. The SGI group had significantly higher rates of difficult cannulation (48.8% vs. 19.1%, p = 0.006) and guidewire insertion technique transformation (44.2% vs. 4.3%, p < 0.001). Additionally, procedure time (49.7 min ± 23.4 min vs. 34.7 min ± 20.5 min, p = 0.002) and cannulation time (5.0 min vs. 4.0 min, p = 0.005) were longer in the SGI group. Technical and clinical success rates, procedure‐related complications, and length of hospitalization were comparable between the two groups. Multivariate analysis revealed that SGI (odds ratio [OR] 4.682, 95% confidence interval [CI] 1.643–13.340, p = 0.004) and hilar biliary tract lesions (OR 3.673, 95% CI 1.236–10.915, p = 0.019) were identified as independent factors for difficult biliary cannulation.
Conclusion
BGI technique may be superior to SGI approach for re‐intervention in patients with RMBO after initial UMS placement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical…
- Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.
ORCID-Profile: Qiao Feng Chen, Zi Hang Xu, You Xiang Chen
Förderung
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Chen, Q. F., Xu, Z. H., Wang, Y. H., Yang, Z. Z., Zhang, S. Y., Xing, Y. W., Li, G. H., Chen, Y. X., Zhou, X. J., & Hong, J. B. (2026). Outcomes of Different Guidewire‐Assisted Techniques for Recurrent Malignant Biliary Obstruction After Uncovered Metallic Stent Placement. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.70065
Vancouver
Chen QF, Xu ZH, Wang YH, Yang ZZ, Zhang SY, Xing YW, et al. Outcomes of Different Guidewire‐Assisted Techniques for Recurrent Malignant Biliary Obstruction After Uncovered Metallic Stent Placement. Journal of Digestive Diseases. 2026. doi:10.1111/1751-2980.70065
BibTeX
@article{Chen2026,
author = {Chen, Qiao Feng and Xu, Zi Hang and Wang, You Hua and Yang, Zhen Zhen and Zhang, Shi Yu and Xing, Ya Wei and Li, Guo Hua and Chen, You Xiang and Zhou, Xiao Jiang and Hong, Jun Bo},
title = {Outcomes of Different Guidewire‐Assisted Techniques for Recurrent Malignant Biliary Obstruction After Uncovered Metallic Stent Placement},
journal = {Journal of Digestive Diseases},
year = {2026},
doi = {10.1111/1751-2980.70065}
}
EUVIMED